Legend Biotech (LEGN) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts LEGN Hot Sheet
Join SI Premium – FREE
Legend Biotech (NASDAQ: LEGN) reported Q2 EPS of $0.03, $0.15 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $255.06 million versus the consensus estimate of $234.23 million.
For earnings history and earnings-related data on Legend Biotech (LEGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
- CAE wins $45.3 million Air Force simulator contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
